Rectal Indomethacin Does not Prevent Post-ERCP Pancreatitis in Consecutive Patients

BACKGROUND & AIMS: Rectal indomethacin, a non-steroidal anti-inflammatory drug, is given to prevent pancreatitis in high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), based on findings from clinical trials. European Society for Gastrointestinal Endoscopy guideli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterology
Main Authors: Levenick, John M., Gordon, Stuart R., Fadden, Linda L., Levy, L. Campbell, Rockacy, Matthew J., Hyder, Sarah M., Lacy, Brian E., Bensen, Steven P., Parr, Douglas D., Gardner, Timothy B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4808426/
https://ncbi.nlm.nih.gov/pubmed/26775631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2015.12.040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados